Redcliffe Labs Appoints Vijay T. S. as Chief People Officer to Strengthen Organizational Growth

IMT News Desk
IMT News Desk
· 2 min read
Redcliffe Labs appoints Vijay T. S. as Chief People Officer to drive people strategy, culture and capability building for its next phase of growth.

Redcliffe Labs has appointed Vijay T. S. as Chief People Officer (CPO), leading the company’s people strategy across talent management, leadership development, organizational culture, performance excellence, and capability building to support Redcliffe Labs’ long-term growth and operational excellence.

Commenting on the appointment, Aditya Kandoi, Founder & CEO, Redcliffe Labs, said, “Vijay brings a strong blend of strategic leadership, operational depth, and transformational people experience built over nearly three decades across diverse industries. As Redcliffe Labs continues to scale, strengthening leadership capability and building an agile, high-performance organization will remain a key priority for us. Vijay’s experience in building scalable organizations and aligning people strategy with business priorities makes him a valuable addition to our leadership team.”

On joining Redcliffe Labs, Vijay T. S., Chief People Officer, Redcliffe Labs, said, “After decades of building organizations, I have learned that purpose is what truly sustains growth. What drew me towards Redcliffe Labs was the sincerity behind its vision. A vision shaped by real experiences and a genuine commitment towards making preventive healthcare more accessible for millions of Indians. My conversations with Aditya Kandoi reflected deep clarity of thought about building an organization that balances growth and impact while remaining equally committed to its people and culture. It feels great to join Redcliffe Labs at this phase of its journey and contribute towards building a strong, purpose-driven organization focused on Better Health Everyday.”

Vijay, an ISB alumni, joins Redcliffe Labs with over 28 years of experience across healthcare, edtech, technology, manufacturing, and global business environments. Over the course of his career, he has led work across human resources, organizational development, business operations, change management, talent strategy, and leadership capability building. He brings deep expertise in organizational design, performance management, employee engagement, leadership hiring, and building scalable, high-performing teams.

Most recently, Vijay served as Chief People Officer at CureBay and before this, he spent nearly eight years at Chegg as Managing Director – India, leading a significant phase of operational growth and organizational scaling for the business in India.

Earlier in his career, Vijay held leadership roles at DuPont, Birlasoft, and Hyundai Motor India, where he built extensive experience across HR transformation, compensation and benefits, employee engagement, capability building, and strategic business partnering.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk